GABRIELLA AMIGE: Open Payments
NPI 1053020479 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,058 in 93 payments from 16 companies in 2025. Trend: 2023 $637 · 2024 $1,408 · 2025 $3,058
Food & beverage: $2,886Education: $172
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $831 |
| Janssen Biotech, Inc. | 11 | $465 |
| Galderma Laboratories, L.P. | 10 | $299 |
| GENZYME CORPORATION | 7 | $295 |
| Regeneron Healthcare Solutions, Inc. | 6 | $266 |
| Lilly USA, LLC | 7 | $220 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $166 |
| Cipher Pharmaceuticals US LLC | 1 | $101 |
| PFIZER INC. | 4 | $77 |
| SANOFI-AVENTIS U.S. LLC | 1 | $72 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, RINVOQ, NEMLUVIO, TALTZ, Natroba, ILUMYA.
Industry payments across PA — which companies pay providers there.
